Carlos Buesa Arjol

Title: Carlos Buesa Arjol: Innovator in Molecular Diagnostics

Introduction

Carlos Buesa Arjol is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of molecular diagnostics, particularly in relation to dementia with Lewy bodies. His innovative work has the potential to improve the diagnosis and treatment of this complex condition.

Latest Patents

Carlos Buesa Arjol holds a patent for a molecular diagnostic method specifically designed for dementia with Lewy bodies. This invention describes methods for diagnosing a specific form of alpha-synucleinopathy associated with the levels of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and alterations in its ubiquityl-ligase activity. The patent also discusses the use of compounds that can modify UCH-L1 levels or its enzymatic activity, which has important applications in diagnosing and treating patients suffering from this form of dementia.

Career Highlights

Carlos is associated with Oryzon Genomics S.A., a company that focuses on developing innovative therapies and diagnostics. His work at Oryzon has positioned him as a key player in the field of molecular diagnostics, contributing to advancements that can significantly impact patient care.

Collaborations

Carlos has collaborated with notable colleagues, including Tamara Maes and Marta Barrachina Castillo. These collaborations have fostered a productive environment for research and innovation, enhancing the development of new diagnostic methods.

Conclusion

Carlos Buesa Arjol is a distinguished inventor whose work in molecular diagnostics is paving the way for better understanding and treatment of dementia with Lewy bodies. His contributions are vital to the ongoing advancements in medical science.